JUSTIN PICKENS: Open Payments
NPI 1790371995 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,213 in 98 payments from 18 companies in 2025. Trend: 2023 $205 · 2024 $193 · 2025 $2,213
Food & beverage: $2,213
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $349 |
| AstraZeneca Pharmaceuticals LP | 12 | $283 |
| Regeneron Healthcare Solutions, Inc. | 6 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $174 |
| Merck Sharp & Dohme LLC | 5 | $152 |
| GENZYME CORPORATION | 5 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $144 |
| Insmed, Inc. | 8 | $144 |
| Paratek Pharmaceuticals, Inc. | 7 | $140 |
| Verona Pharma, Inc. | 5 | $105 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, GLASSIA, Arikayce, NUZYRA, AIRSUPRA, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
